ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for ANIP

Stock NameANI Pharmaceuticals Inc
TickerANIP(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS00182C1036
LEI5493000T6CXTND40YH31

Show aggregate ANIP holdings

News associated with ANIP

HC Wainwright Forecasts Strong Price Appreciation for ANI Pharmaceuticals (NASDAQ:ANIP) Stock
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) had its target price increased by HC Wainwright from $93.00 to $121.00 in a report issued on Wednesday, MarketBeat Ratings reports. The firm currently has a “buy” rating on the specialty pharmaceutical company’s stock. HC Wainwright’s price objective would suggest a potential upside of 24.13% from the stock’s […] - 2025-09-19 03:05:01
ANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 12-Month High Following Analyst Upgrade
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) hit a new 52-week high on Tuesday after Guggenheim raised their price target on the stock from $86.00 to $114.00. Guggenheim currently has a buy rating on the stock. ANI Pharmaceuticals traded as high as $96.66 and last traded at $96.30, with a volume of 66131 shares […] - 2025-09-10 02:20:55
ANI Pharmaceuticals (NASDAQ:ANIP) COO Sells $4,618,078.50 in Stock
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) COO Muthusamy Shanmugam sold 52,990 shares of the firm’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $87.15, for a total transaction of $4,618,078.50. Following the completion of the sale, the chief operating officer directly owned 531,920 shares […] - 2025-08-21 05:19:08
Deutsche Bank AG Trims Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Deutsche Bank AG trimmed its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 6.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 218,086 shares of the specialty pharmaceutical company’s stock after selling 14,242 shares during […] - 2025-08-15 05:15:08
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Expected to Rise, Truist Financial Analyst Says
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) had its target price raised by investment analysts at Truist Financial from $65.00 to $77.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “hold” rating on the specialty pharmaceutical company’s stock. Truist Financial’s target price suggests a potential downside of 12.84% […] - 2025-08-13 02:46:43
Victory Capital Management Inc. Has $1.13 Million Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Victory Capital Management Inc. grew its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 22.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,863 shares of the specialty pharmaceutical company’s stock after buying an additional 3,086 shares during the period. Victory Capital […] - 2025-07-31 05:28:47
Bank of New York Mellon Corp Reduces Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Bank of New York Mellon Corp lessened its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 3.7% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 119,262 shares of the specialty pharmaceutical company’s stock after selling 4,570 shares during the quarter. Bank of New York Mellon Corp’s holdings in ANI Pharmaceuticals […] - 2025-07-23 04:30:44
Louisiana State Employees Retirement System Has $522,000 Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Louisiana State Employees Retirement System cut its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 2.5% during the first quarter, Holdings Channel.com reports. The firm owned 7,800 shares of the specialty pharmaceutical company’s stock after selling 200 shares during the quarter. Louisiana State Employees Retirement System’s holdings in ANI Pharmaceuticals were worth $522,000 […] - 2025-07-21 05:16:50
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives $78.88 Consensus Target Price from Analysts
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ratings firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the […] - 2025-07-18 02:23:01
GAMMA Investing LLC Has $95,000 Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
GAMMA Investing LLC lifted its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 163.8% during the first quarter, Holdings Channel.com reports. The firm owned 1,419 shares of the specialty pharmaceutical company’s stock after purchasing an additional 881 shares during the period. GAMMA Investing LLC’s holdings in ANI Pharmaceuticals were worth $95,000 […] - 2025-07-07 04:17:14
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives $80.13 Average PT from Brokerages
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) has received an average recommendation of “Buy” from the nine brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The […] - 2025-06-23 02:14:07
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives $80.13 Average Target Price from Analysts
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) has received a consensus recommendation of “Buy” from the nine analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. […] - 2025-05-29 02:27:28
Surprising Analyst 12-Month Target For VIOO
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-13 08:45:24
Comerica Bank Has $1.04 Million Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Comerica Bank lowered its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 30.1% in the 4th quarter, HoldingsChannel reports. The firm owned 18,830 shares of the specialty pharmaceutical company’s stock after selling 8,099 shares during the period. Comerica Bank’s holdings in ANI Pharmaceuticals were worth $1,041,000 at the end of the […] - 2025-05-13 05:42:52
MetLife Investment Management LLC Has $630,000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
MetLife Investment Management LLC increased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 6.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,397 shares of the specialty pharmaceutical company’s stock after buying an additional 675 […] - 2025-05-05 06:01:03
Dimensional Fund Advisors LP Raises Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Dimensional Fund Advisors LP raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 685,730 shares of the specialty pharmaceutical company’s stock after purchasing an additional 30,420 […] - 2025-05-05 05:20:53
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of “Buy” from Analysts
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) has been given an average rating of “Buy” by the nine analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to […] - 2025-05-01 02:12:50
Legal & General Group Plc Acquires 2,585 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Legal & General Group Plc increased its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 5.6% during the fourth quarter, Holdings Channel.com reports. The fund owned 48,425 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,585 shares during the quarter. Legal & General Group Plc’s holdings in ANI […] - 2025-04-24 05:18:54
Invesco Ltd. Lowers Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Invesco Ltd. lowered its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 10.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 197,545 shares of the specialty pharmaceutical company’s stock after selling 22,814 shares during the quarter. Invesco […] - 2025-04-23 05:08:58
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Expected to Rise, Truist Financial Analyst Says
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) had its target price upped by analysts at Truist Financial from $62.00 to $65.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “hold” rating on the specialty pharmaceutical company’s stock. Truist Financial’s price target points to a potential downside of 5.73% from the company’s […] - 2025-04-23 02:42:48
Vanguard Group Inc. Sells 33,739 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Vanguard Group Inc. reduced its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,314,372 shares of the specialty pharmaceutical company’s stock after selling 33,739 shares during the quarter. Vanguard […] - 2025-04-11 04:52:47
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Lowered by StockNews.com
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday. Other equities analysts have also recently issued reports about the stock. Leerink Partnrs raised shares of ANI Pharmaceuticals to a “strong-buy” rating in a research note on […] - 2025-04-10 03:13:02
Brokerages Set ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) PT at $79.75
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The […] - 2025-04-09 02:04:49
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Position Trimmed by Corebridge Financial Inc.
Corebridge Financial Inc. reduced its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 7.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,778 shares of the specialty pharmaceutical company’s stock after selling 762 shares during the quarter. Corebridge […] - 2025-04-08 04:27:01
Thrivent Financial for Lutherans Reduces Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Thrivent Financial for Lutherans trimmed its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 1.5% in the 4th quarter, HoldingsChannel reports. The firm owned 12,828 shares of the specialty pharmaceutical company’s stock after selling 200 shares during the quarter. Thrivent Financial for Lutherans’ holdings in ANI Pharmaceuticals were worth $709,000 as of its […] - 2025-04-03 04:16:46
ANI Pharmaceuticals (NASDAQ:ANIP) Now Covered by Analysts at Jefferies Financial Group
Jefferies Financial Group initiated coverage on shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $80.00 target price on the specialty pharmaceutical company’s stock. Several other analysts have also recently commented on ANIP. StockNews.com cut shares of ANI […] - 2025-03-17 04:26:54
JPMorgan Chase & Co. Begins Coverage on ANI Pharmaceuticals (NASDAQ:ANIP)
JPMorgan Chase & Co. started coverage on shares of ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) in a research report issued to clients and investors on Wednesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $85.00 price target on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a […] - 2025-03-14 04:34:45
Illinois Municipal Retirement Fund Decreases Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Illinois Municipal Retirement Fund lowered its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 8.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 8,533 shares of the specialty pharmaceutical company’s stock after selling 799 shares during the quarter. Illinois Municipal Retirement Fund’s […] - 2025-03-05 08:46:59
ANI Pharmaceuticals (NASDAQ:ANIP) Cut to Sell at StockNews.com
StockNews.com downgraded shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) from a hold rating to a sell rating in a report released on Monday morning. ANIP has been the subject of several other research reports. Leerink Partners assumed coverage on shares of ANI Pharmaceuticals in a research note on Wednesday, December 11th. They set an […] - 2025-03-04 04:50:49
Brokerages Set ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Price Target at $77.71
Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) have been given an average rating of “Buy” by the eight research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has assigned a strong buy […] - 2025-02-18 04:13:03

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ANIP holdings

DateNumber of ANIP Shares HeldBase Market Value of ANIP SharesLocal Market Value of ANIP SharesChange in ANIP Shares HeldChange in ANIP Base ValueCurrent Price per ANIP Share HeldPrevious Price per ANIP Share Held
2025-12-15 (Monday)2,174USD 177,203ANIP holding increased by 2435USD 177,2030USD 2,435 USD 81.5101 USD 80.3901
2025-12-12 (Friday)2,174USD 174,768ANIP holding decreased by -3783USD 174,7680USD -3,783 USD 80.3901 USD 82.1302
2025-12-11 (Thursday)2,174USD 178,551ANIP holding increased by 218USD 178,5510USD 218 USD 82.1302 USD 82.0299
2025-12-10 (Wednesday)2,174USD 178,333ANIP holding increased by 782USD 178,3330USD 782 USD 82.0299 USD 81.6702
2025-12-09 (Tuesday)2,174USD 177,551ANIP holding increased by 718USD 177,5510USD 718 USD 81.6702 USD 81.3399
2025-12-08 (Monday)2,174USD 176,833ANIP holding decreased by -935USD 176,8330USD -935 USD 81.3399 USD 81.77
2025-12-05 (Friday)2,174USD 177,768ANIP holding decreased by -2109USD 177,7680USD -2,109 USD 81.77 USD 82.7401
2025-12-04 (Thursday)2,174USD 179,877ANIP holding increased by 152USD 179,8770USD 152 USD 82.7401 USD 82.6702
2025-12-03 (Wednesday)2,174ANIP holding decreased by -35USD 179,725ANIP holding decreased by -1678USD 179,725-35USD -1,678 USD 82.6702 USD 82.12
2025-12-02 (Tuesday)2,209ANIP holding increased by 14USD 181,403ANIP holding decreased by -4009USD 181,40314USD -4,009 USD 82.12 USD 84.4702
2025-12-01 (Monday)2,195USD 185,412ANIP holding decreased by -834USD 185,4120USD -834 USD 84.4702 USD 84.8501
2025-11-28 (Friday)2,195USD 186,246ANIP holding increased by 1076USD 186,2460USD 1,076 USD 84.8501 USD 84.3599
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ANIP by Blackrock for IE00B3VWM098

Show aggregate share trades of ANIP

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-3584.16581.750 81.992USD -2,870 67.97 Loss of -491 on sale
2025-12-02BUY1484.65081.860 82.139USD 1,150 67.90
2025-11-25SELL-2184.67381.540 81.853USD -1,719 67.51 Loss of -301 on sale
2025-11-24BUY1,23881.55078.402 78.717USD 97,452 67.44
2025-11-17SELL-3385.17081.680 82.029USD -2,707 67.12 Loss of -492 on sale
2025-11-12SELL-389.57087.210 87.446USD -262 66.84 Loss of -62 on sale
2025-11-06SELL-394.45690.040 90.482USD -271 66.37 Loss of -72 on sale
2025-11-05SELL-3095.57092.385 92.704USD -2,781 66.23 Loss of -794 on sale
2025-11-04SELL-695.12092.370 92.645USD -556 66.09 Loss of -159 on sale
2025-11-03SELL-694.22888.960 89.487USD -537 65.94 Loss of -141 on sale
2025-10-28BUY993.29093.640 93.605USD 842 65.38
2025-10-24SELL-394.24097.000 96.724USD -290 65.07 Loss of -95 on sale
2025-10-15BUY1890.10090.610 90.559USD 1,630 63.94
2025-10-02BUY389.13090.620 90.471USD 271 63.65
2025-09-30BUY691.60093.210 93.049USD 558 63.33
2025-08-21SELL-391.14091.540 91.500USD -275 62.45 Loss of -87 on sale
2025-07-31BUY963.35065.070 64.898USD 584 62.28
2025-06-30SELL-665.25066.080 65.997USD -396 61.86 Loss of -25 on sale
2025-06-25SELL-365.91066.860 66.765USD -200 61.78 Loss of -15 on sale
2025-06-20SELL-665.56065.920 65.884USD -395 61.68 Loss of -25 on sale
2025-05-23BUY357.79057.860 57.853USD 174 61.75
2025-05-19SELL-360.16060.200 60.196USD -181 61.84 Profit of 5 on sale
2025-05-15SELL-959.53061.240 61.069USD -550 61.87 Profit of 7 on sale
2025-05-12SELL-362.30067.640 67.106USD -201 61.88 Loss of -16 on sale
2025-05-09SELL-366.30077.000 75.930USD -228 61.84 Loss of -42 on sale
2025-04-30SELL-370.82071.160 71.126USD -213 61.20 Loss of -30 on sale
2025-04-24SELL-669.64070.050 70.009USD -420 60.84 Loss of -55 on sale
2025-04-17SELL-369.21070.480 70.353USD -211 60.42 Loss of -30 on sale
2025-04-15SELL-969.55069.920 69.883USD -629 60.23 Loss of -87 on sale
2025-04-14SELL-968.72069.630 69.539USD -626 60.14 Loss of -85 on sale
2025-04-09SELL-1266.01067.490 67.342USD -808 59.93 Loss of -89 on sale
2025-04-07SELL-2166.99068.820 68.637USD -1,441 59.81 Loss of -185 on sale
2025-04-04SELL-3067.52068.400 68.312USD -2,049 59.72 Loss of -258 on sale
2025-03-31BUY366.95067.800 67.715USD 203 59.42
2025-03-19SELL-664.87065.040 65.023USD -390 58.70 Loss of -38 on sale
2025-03-14SELL-1862.49063.600 63.489USD -1,143 58.49 Loss of -90 on sale
2025-03-13SELL-661.46063.330 63.143USD -379 58.45 Loss of -28 on sale
2025-03-12SELL-10263.26064.430 64.313USD -6,560 58.38 Loss of -605 on sale
2025-03-07SELL-660.62062.760 62.546USD -375 58.30 Loss of -25 on sale
2025-03-06SELL-961.05062.470 62.328USD -561 58.26 Loss of -37 on sale
2025-03-03SELL-358.46062.040 61.682USD -185 58.22 Loss of -10 on sale
2025-02-28SELL-1861.89062.620 62.547USD -1,126 58.16 Loss of -79 on sale
2025-02-26SELL-355.01055.180 55.163USD -165 58.27 Profit of 9 on sale
2025-02-25SELL-954.51056.030 55.878USD -503 58.33 Profit of 22 on sale
2025-02-18BUY1558.73059.830 59.720USD 896 58.30
2025-02-13BUY359.19059.540 59.505USD 179 58.26
2025-02-12BUY359.68060.020 59.986USD 180 58.23
2025-02-11BUY959.85060.680 60.597USD 545 58.19
2025-02-06BUY2760.19061.000 60.919USD 1,645 58.06
2025-01-27BUY360.42060.780 60.744USD 182 57.82
2024-12-30BUY1554.21054.450 54.426USD 816 57.96
2024-12-06BUY1256.97057.480 57.429USD 689 57.95
2024-12-05BUY355.99057.080 56.971USD 171 58.01
2024-12-04BUY1556.86057.670 57.589USD 864 58.05
2024-11-29BUY1557.23059.330 59.120USD 887 58.14
2024-11-27BUY1259.39059.560 59.543USD 715 58.03
2024-11-26BUY357.86058.830 58.733USD 176 58.04
2024-11-21BUY1555.86056.380 56.328USD 845 58.18
2024-11-20BUY955.10056.240 56.126USD 505 58.36
2024-11-18BUY3655.25057.200 57.005USD 2,052 58.72
2024-11-12BUY2461.00062.910 62.719USD 1,505 58.56
2024-11-08BUY1561.44062.270 62.187USD 933 58.36
2024-11-07BUY4558.38059.920 59.766USD 2,689 58.36
2024-11-06BUY658.40060.140 59.966USD 360 58.35
2024-10-31BUY357.25058.470 58.348USD 175 58.94
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ANIP

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1941,035062,69465.5%
2025-09-1872,43315,812127,36656.9%
2025-09-17122,1913,115207,45658.9%
2025-09-1635,7570163,99721.8%
2025-09-1578,19212144,94053.9%
2025-09-1230,941065,76247.0%
2025-09-1139,4190128,05430.8%
2025-09-1072,16858132,79754.3%
2025-09-09142,073160263,39553.9%
2025-09-0835,4900162,39021.9%
2025-09-0551,45850145,84635.3%
2025-09-0465,824100152,24143.2%
2025-09-0362,1760181,21034.3%
2025-09-0244,4730124,88935.6%
2025-08-2940,67425093,99243.3%
2025-08-2899,1680164,69860.2%
2025-08-2729,32710090,65032.4%
2025-08-2665,7770199,75832.9%
2025-08-2537,903364120,27531.5%
2025-08-2258,26265139,88541.6%
2025-08-2169,041150233,24029.6%
2025-08-2040,2980144,83227.8%
2025-08-19128,5790350,79136.7%
2025-08-1872,497100270,47826.8%
2025-08-1563,2900374,91316.9%
2025-08-1491,4458,700225,23240.6%
2025-08-13105,5354,110254,50141.5%
2025-08-12176,94729,770533,07033.2%
2025-08-11231,2655,230706,29832.7%
2025-08-08294,25516,527803,62336.6%
2025-08-07220,706185397,61655.5%
2025-08-06294,1680430,47468.3%
2025-08-0548,125071,57567.2%
2025-08-0435,419053,13966.7%
2025-08-0159,471092,37464.4%
2025-07-3147,901084,85256.5%
2025-07-3045,147095,24847.4%
2025-07-29109,8130199,72655.0%
2025-07-2874,1490114,22664.9%
2025-07-25101,3830158,63863.9%
2025-07-2480,0320117,73168.0%
2025-07-2388,6610122,05972.6%
2025-07-2257,1201,84570,26481.3%
2025-07-2159,2640141,59341.9%
2025-07-1873,816200109,09167.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy